Literature DB >> 12797161

Doppler in non-immune hydrops fetalis.

G Tulzer1, S Gudmundsson, D C Wood, A W Cohen, S Weiner, J C Huhta.   

Abstract

Fetal ultrasound studies were performed on 24 fetuses with non-immune hydrops to evaluate echocardiographic and cardiovascular Doppler parameters that may be useful in assessing hemodynamics and in predicting outcome. Of all cardiovascular parameters analyzed, only the presence of abnormal pulsations in the umbilical vein (p < 0.001) was found to be significantly different between the 11 survivors and 13 non-survivors. In a smaller subset of 12 fetuses, in whom inferior vena caval waveforms were recorded, survivors (n = 6) had a significantly lower percentage of retrograde flow in the inferior vena cava (p < 0.001) and higher inferior vena caval E/V velocity ratio (p < 0.001) than non-survivors (n = 6). Sixteen of the 24 cases examined had abnormal umbilical venous pulsations; 12 of the 16 (75%) died including all fetuses with hydrops due to twin-to-twin transfusion or congenital heart disease. When fetuses with pulsatile flow in the umbilical vein were compared with fetuses with normal umbilical venous flow, the following significant differences were found: lower right and left ventricular output velocities, larger inferior vena caval diameter, decreased shortening fractions of the right and left ventricles, and lower peak velocities at the aortic and pulmonary valves and in the ductus arteriosus. Copyright 1994 International Society of Ultrasound in Obstetrics and Gynecology

Entities:  

Year:  1994        PMID: 12797161     DOI: 10.1046/j.1469-0705.1994.04040279.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Venous Doppler in the evaluation of fetal hydrops.

Authors:  C Hofstaetter; S Gudmundsson
Journal:  Obstet Gynecol Int       Date:  2010-05-05

Review 2.  Guidelines for the evaluation of heart failure in the fetus with or without hydrops.

Authors:  J C Huhta
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

Review 3.  Evaluation and Management of Fetal Cardiac Function and Heart Failure.

Authors:  Erik Michelfelder; Catherine Allen; Lindsay Urbinelli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.